Patient-centric clinical trials represent a transformative approach in the realm of medical research, placing the needs and perspectives of patients at the forefront. Emphasizing collaboration and engagement, these trials aim to enhance the overall patient experience, ensuring their voices are heard in the development and execution of research protocols. In patient-centric trials, there is a conscious effort to streamline participation processes, reducing burdens on patients while maximizing the collection of meaningful data. Transparent communication, simplified consent procedures, and accessible trial information contribute to fostering a sense of empowerment and understanding among participants.
The integration of patient input in study design and endpoint selection contributes to the relevance and effectiveness of clinical trials. Patient-centricity extends beyond data collection to encompass the overall well-being of participants, recognizing their unique needs and challenges throughout the trial journey. Patient-centric clinical trials embody a paradigm shift, aligning with the principles of personalized medicine and recognizing the individuality of each patient. As this approach gains prominence, it not only promotes greater patient satisfaction but also contributes to more robust and applicable research outcomes.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico